/

Case Studies

/

Biotech firm leverages data to uncover high revenue growth opportunity

Biotech firm leverages data to uncover high revenue growth opportunity

Biotech firm leverages data to uncover high revenue growth opportunity

How data-driven interventions reversed prescription declines and unlocked $105m

How data-driven interventions reversed prescription declines and unlocked $105m

$105M revenue growth opportunity

Created physician personas

Prioritized by prescription volume

Recommended optimized strategies

The challenge

Strategic response to declining sales in a flagship drug

A leading pharmaceutical company was grappling with a significant decline in the sales volume of its flagship drug, which normally generates over $5 billion in annual sales. The company identified that fewer than 30% of physicians were responsible for a substantial loss of approximately $400 million in prescription sales. In response, the company aimed to predict which physicians were most likely to continue declining their prescription behavior and proactively engage with them to boost sales.

Key challenges

  • Identifying at-risk physicians

  • Predicting future prescription trends

  • Engaging physicians to reverse decline

  • Efficiently allocating resources

The solution

Reviving prescription behavior

Identifying key drivers

Defined decline drivers

Prioritized physicians

Segmented for actions

Predicting prescription decline

Developed predictive models

Analyzed data

Identified behavior nudges and triggers

Implementation approach

1

Data analysis

  • Evaluated key data

  • Focused on calls and impressions

  • Identified 1,800+ features

2

Model development

  • Applied ML & regression

  • Validated decline hypotheses

  • Identified prescribing drivers

3

Targeted engagement

  • Prioritized high-risk physicians

  • Tailored marketing strategies

  • Measured impact

The impact

Transforming sales strategy to recover $105 million in revenue

Revenue opportunity

  • Identified 1,300+ at-risk physicians

  • $105M revenue potential

  • Targeted sales recovery

Segmentation strategy

  • Created physician personas

  • Prioritized volume

  • Improved targeting

Recommendations

  • Engaged stakeholders

  • Customized messaging

  • Enhanced co-pay distribution

Looking ahead

Ongoing monitoring

  • Track physician behavior to proactively address further declines

Scaling targeted campaigns

  • Expand successful interventions across additional regions

Continuous optimization

  • Refine machine learning models for sustained growth and impact